Prophylactic administration of antibiotics unnecessary following ultrasound-guided biopsy and ablation therapy for liver tumors: Open-labeled randomized prospective study

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Shuichi SatoYoshikazu Kinoshita

Abstract

To determine the prophylactic effect of antibiotics administration in the prevention of infection following an ultrasound-guided percutaneous liver biopsy or treatment of liver tumors, we performed an open-labeled randomized prospective study of patients who received prophylactic antibiotics after undergoing those procedures. We studied 101 patients, with ultrasound-guided percutaneous aspiration biopsies of the liver performed in 48 to diagnose diffuse liver diseases or liver tumors, while percutaneous ethanol-injection therapy was performed in two patients with malignant liver tumors and percutaneous radiofrequency ablation was performed in 51 patients. An oral administration of levofloxacin at 400 mg/day was given to 50 of the enrolled patients from the morning of the treatment day for three days. Preventive antibiotics were not administered to the remaining 51 patients. Body temperature, peripheral blood leukocyte number, c-reactive protein, alanine aminotransferase, and lactic dehydrogenase were measured daily for three days after treatment. Most parameters changed following percutaneous treatments of liver tumors, though no significant differences were seen between the patients treated with antibiotics and those untreated...Continue Reading

References

Jan 1, 1989·European Journal of Clinical Pharmacology·C SilvainM Beauchant
May 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K D LindorA R Zinsmeister
Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
Sep 28, 2001·The Annals of Pharmacotherapy·J A Paladino
Aug 23, 2003·AJR. American Journal of Roentgenology·Thierry de BaèreDominique Elias
Dec 12, 2003·Cardiovascular and Interventional Radiology·Jay W PattiBradford J Wood
Nov 30, 2004·Liver International : Official Journal of the International Association for the Study of the Liver·Guido PoggiGiovanni Bernado
Aug 4, 2006·Gastroentérologie Clinique Et Biologique·Dominique EliasThierry De Baere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
Jun WangYou Cheng Zhang
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Briain D MacNeillIk-Kyung Jang
© 2022 Meta ULC. All rights reserved